Consumption of Galacto-Oligosaccharides Increases Iron Absorption from Ferrous Fumarate: A Stable Iron Isotope Study in Iron-Depleted Young Women

J Nutr. 2019 May 1;149(5):738-746. doi: 10.1093/jn/nxy327.

Abstract

Background: Animal studies suggest prebiotics can increase iron absorption, but results from human studies are equivocal.

Objectives: In iron-depleted women, before (baseline) and after daily consumption of galacto-oligosaccharides (GOS) for 4 wk, we sought to assess fractional iron absorption (FIA) from an iron supplement given with and without single doses of GOS in test meals or water.

Methods: In all women (n = 34; median serum ferritin concentration = 16.4 µg/L), FIA from doses of 14 mg iron labeled with stable isotopes was measured in the following conditions at baseline: 1) FIA from ferrous fumarate (FeFum) in water given with and without 15 g GOS; 2) FIA from FeFum in a test meal given with and without 15 g GOS; 3) FIA from ferrous sulfate (FeSO4) in a test meal given without 15 g GOS. All subjects then consumed ∼15 g GOS daily for 4 wk. Then the following conditions were tested: 4) FIA from FeFum in a test meal with and without 15 g GOS; and 5) FIA from FeSO4 in a test meal with 15 g GOS. FIA was measured as erythrocyte incorporation of stable isotopes.

Results: At baseline, GOS significantly increased FIA from FeFum when given with water (+61%; P < 0.001) and the meal (+28%; P = 0.002). After 4 wk of GOS consumption, GOS again significantly increased FIA from FeFum in the meal (+29%; P = 0.044). However, compared with baseline, consumption of GOS for 4 wk did not significantly enhance absorption from FeFum in the meal given without GOS. FIA from FeSO4 given with GOS in a meal after 4 wk of GOS consumption was not significantly greater than FIA from FeSO4 in a meal without GOS at baseline.

Conclusions: In iron-depleted women, GOS given with FeFum increases FIA, but 4 wk of GOS consumption did not enhance this effect. The study was registered at clinicaltrials.gov as NCT03325270.

Keywords: GOS; absorption; deficiency; ferrous fumarate; galacto-oligosaccharides; iron; prebiotic; stable isotope; women.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Anemia, Iron-Deficiency / blood*
  • Anemia, Iron-Deficiency / drug therapy
  • Dietary Supplements
  • Erythrocytes / metabolism
  • Female
  • Ferritins / blood
  • Ferrous Compounds / blood
  • Ferrous Compounds / pharmacokinetics*
  • Galactose / pharmacology*
  • Galactose / therapeutic use
  • Humans
  • Intestinal Absorption / drug effects*
  • Iron / blood
  • Iron / pharmacokinetics*
  • Iron Isotopes / blood
  • Meals
  • Oligosaccharides / pharmacology*
  • Oligosaccharides / therapeutic use
  • Prebiotics*
  • Young Adult

Substances

  • Ferrous Compounds
  • Iron Isotopes
  • Oligosaccharides
  • Prebiotics
  • ferrous sulfate
  • Ferritins
  • Iron
  • ferrous fumarate
  • Galactose

Associated data

  • ClinicalTrials.gov/NCT03325270